Skip to Content

Vaccines, Volume 10, Issue 2

2022 February - 207 articles

Cover Story: Shigella sonnei and flexneri remain among the top bacterial causes of dysentery and severe diarrhea in children. Several vaccine developers are in advanced clinical studies with highly promising multivalent formulations; a safe and efficacious Shigella vaccine would represent a great scientific achievement. Nonetheless, such a vaccine would arrive in the context of increasingly crowded and costly childhood immunization programs, among a myriad of other new and improved vaccines currently or soon on the market. There is thus no guarantee that a Shigella vaccine would become an adoption priority by those low- and middle-income countries that could benefit the most. We discuss some of the major determinants of the introduction of Shigella vaccines and the importance of developing a succinct, compelling public health value proposition. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (207)

  • Review
  • Open Access
67 Citations
18,756 Views
32 Pages

Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective

  • Abid A. Haseeb,
  • Omar Solyman,
  • Mokhtar M. Abushanab,
  • Ahmed S. Abo Obaia and
  • Abdelrahman M. Elhusseiny

21 February 2022

Vaccination efforts as a mitigation strategy in the corona virus disease 2019 (COVID-19) pandemic are fully underway. A vital component of understanding the optimal clinical use of these vaccines is a thorough investigation of adverse events followin...

  • Article
  • Open Access
12 Citations
3,117 Views
8 Pages

SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot

  • Lutz Achtnichts,
  • Arkady Ovchinnikov,
  • Barbara Jakopp,
  • Michael Oberle,
  • Krassen Nedeltchev,
  • Christoph Andreas Fux,
  • Johann Sellner and
  • Oliver Findling

21 February 2022

Evidence suggests limited development of protective IgG responses to mRNA-based vaccines in sphingosine-1-phosphate receptor (S1PR)-modulator treated individuals with multiple sclerosis (MS). We studied the extent of the humoral immune response after...

  • Article
  • Open Access
22 Citations
4,643 Views
15 Pages

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial

  • Petra Girardi,
  • Shushan Harutyunyan,
  • Irene Neuhauser,
  • Katharina Glaninger,
  • Orsolya Korda,
  • Gábor Nagy,
  • Eszter Nagy,
  • Valéria Szijártó,
  • Denes Pall and
  • Frank J. Malinoski
  • + 3 authors

21 February 2022

Background: Shigella spp. and enterotoxigenic Escherichia coli (ETEC) cause high morbidity and mortality worldwide, yet no licensed vaccines are available to prevent corresponding infections. A live attenuated non-invasive Shigella vaccine strain lac...

  • Article
  • Open Access
9 Citations
2,811 Views
12 Pages

The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection

  • Chung-Yi Cheng,
  • Te-Chao Fang,
  • Hung-Wei Liao,
  • Tso-Hsiao Chen,
  • Jer-Hwa Chang,
  • Yen-Chung Lin,
  • Chih-Chin Kao,
  • Ming-Che Liu,
  • Hui-Wen Chang and
  • Yuh-Mou Sue
  • + 3 authors

21 February 2022

Background: Chronic kidney disease (CKD) patients tend to have a reduced immune response to infection and vaccination. The efficacy of current available COVID-19 vaccines in CKD patients has not been widely evaluated. Methods: In the present study, t...

  • Review
  • Open Access
8 Citations
4,760 Views
24 Pages

Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines

  • Mepur H. Ravindranath,
  • Narendranath M. Ravindranath,
  • Senthamil R. Selvan,
  • Edward J. Filippone,
  • Carly J. Amato-Menker and
  • Fatiha El Hilali

21 February 2022

Leukocyte cell-surface HLA-I molecules, involved in antigen presentation of peptides to CD8+ T-cells, consist of a heavy chain (HC) non-covalently linked to β2-microglobulin (β2m) (Face-1). The HC amino acid composition varies across all si...

  • Article
  • Open Access
10 Citations
3,372 Views
12 Pages

Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece

  • Foteini Malli,
  • Ioannis C. Lampropoulos,
  • Dimitrios Papagiannis,
  • Ioanna V. Papathanasiou,
  • Zoe Daniil and
  • Konstantinos I. Gourgoulianis

21 February 2022

The available coronavirus disease 2019 (COVID-19) vaccines have shown their effectiveness in clinical trials. We aimed to assess the real-world effects of SARS-CoV-2 vaccinations in Greece. We combined national data on vaccinations, SARS-CoV-2 cases,...

  • Communication
  • Open Access
6 Citations
2,581 Views
9 Pages

20 February 2022

To control the coronavirus disease 2019 (COVID-19) pandemic, the Japanese government is promoting vaccination, which many people are willing to accept; however, some are reluctant to receive vaccinations. The purpose of this study was to analyze the...

  • Article
  • Open Access
4 Citations
4,657 Views
17 Pages

Protection of Cattle against Epizootic Bovine Abortion (EBA) Using a Live Pajaroellobacter abortibovis Vaccine

  • Myra T. Blanchard,
  • Mike B. Teglas,
  • Mark L. Anderson,
  • Peter F. Moore,
  • Bret R. McNabb,
  • Kassidy M. Collins,
  • Bret V. Yeargan and
  • Jeffrey L. Stott

19 February 2022

Epizootic bovine abortion (EBA) is an arthropod-borne bacterial disease that causes significant economic loss for cattle producers in the western United States. The etiologic agent, Pajaroellobacter abortibovis, is an intracellular pathogen that has...

  • Article
  • Open Access
6 Citations
3,428 Views
10 Pages

19 February 2022

Systemic vaccination with the BNT162b2 mRNA vaccine stimulates the humoral response. Our study aimed to compare the intensity of the humoral immune response, measured by SARS-CoV-2 IgG, SARS-CoV-2 IgM, and S-RBD-neutralizing IgG antibody levels after...

  • Article
  • Open Access
14 Citations
4,289 Views
11 Pages

Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals

  • Ji-Young Hwang,
  • Yunhwa Kim,
  • Kyung-Min Lee,
  • Eun-Jeong Jang,
  • Chang-Hoon Woo,
  • Chang-Ui Hong,
  • Seok-Tae Choi,
  • Sivilay Xayaheuang,
  • Jong-Geol Jang and
  • Hosun Park
  • + 1 author

18 February 2022

In the face of a global COVID-19 vaccine shortage, an efficient vaccination strategy is required. Therefore, the immunogenicity of single or double COVID-19 vaccination doses (ChAdOX1, BNT162b2, or mRNA-1273) of SARS-CoV-2-recovered individuals was c...

  • Article
  • Open Access
17 Citations
4,773 Views
16 Pages

18 February 2022

The COVID-19 pandemics has caused the death of almost six million people worldwide. In order to establish collective immunity, the first vaccines that were approved in Germany were the vector virus-based vaccine Vaxzevria and the mRNA vaccines Comirn...

  • Article
  • Open Access
23 Citations
3,611 Views
8 Pages

18 February 2022

Background: We evaluated the post-booster (BNT162b2) antibody responses in Singapore. Methods: Participants (n = 43) were tested pre-booster and 20/30/60/90 days post-booster. Participants were boosted 120–240 days (mean 214 days) after their s...

  • Article
  • Open Access
3 Citations
3,200 Views
11 Pages

Is Mandatory Vaccination in Population over 60 Adequate to Control the COVID-19 Pandemic in E.U.?

  • Nikolaos P. Rachaniotis,
  • Thomas K. Dasaklis,
  • Filippos Fotopoulos,
  • Michalis Chouzouris,
  • Vana Sypsa,
  • Antigone Lyberaki and
  • Platon Tinios

18 February 2022

Vaccine hesitancy, which potentially leads to the refusal or delayed acceptance of COVID-19 vaccines, is considered a key driver of the increasing death toll from the pandemic in the EU. The European Commission and several member states’ govern...

  • Article
  • Open Access
13 Citations
3,210 Views
10 Pages

Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation

  • Caroline Pabst,
  • Louise Benning,
  • Nora Liebers,
  • Maike Janssen,
  • Leandra Caille,
  • Claudius Speer,
  • Lixiazi He,
  • Maria-Luisa Schubert,
  • Laura Simons and
  • Thomas Luft
  • + 8 authors

18 February 2022

The COVID-19 pandemic threatens patients with a compromised immune and endothelial system, including patients who underwent allogeneic stem cell transplantation (alloSCT). Thus, there is an unmet need for optimizing vaccination management in this hig...

  • Review
  • Open Access
44 Citations
5,667 Views
14 Pages

Towards a Four-Component GMMA-Based Vaccine against Shigella

  • Francesca Micoli,
  • Usman N. Nakakana and
  • Francesco Berlanda Scorza

18 February 2022

Shigellosis remains a major public health problem around the world; it is one of the leading causes of diarrhoeal disease in low- and middle-income countries, particularly in young children. The increasing reports of Shigella cases associated with an...

  • Article
  • Open Access
10 Citations
3,017 Views
14 Pages

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis

  • Michael Jahn,
  • Johannes Korth,
  • Oliver Dorsch,
  • Olympia Evdoxia Anastasiou,
  • Adalbert Krawczyk,
  • Leonie Brochhagen,
  • Lukas van de Sand,
  • Burkhard Sorge-Hädicke,
  • Bartosz Tyczynski and
  • Andreas Kribben
  • + 4 authors

18 February 2022

This study analyzed binding and neutralizing antibody titers up to 6 months after standard vaccination with BNT162b2 (two doses of 30 µg each) in SARS-CoV-2 naïve patients (n = 59) on hemodialysis. Humoral vaccine responses were measured b...

  • Article
  • Open Access
2,790 Views
8 Pages

COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and Outcomes

  • Yulin Cao,
  • Di Wu,
  • Kuo Zeng,
  • Lei Chen,
  • Jianming Yu,
  • Wenjuan He,
  • Li Chen,
  • Wenxiang Ren,
  • Fei Gao and
  • Qiubai Li
  • + 4 authors

18 February 2022

(1) Background: Although there are extensive data on admission co-variates and outcomes of persons with coronavirus infectious disease-2019 (COVID-19) at diverse geographic sites, there are few, if any, subject-level comparisons between sites in regi...

  • Case Report
  • Open Access
10 Citations
7,268 Views
7 Pages

Aseptic Meningitis, Mucocutaneous Lesions and Arthritis after COVID-19 Vaccination in a 15-Year-Old Boy

  • Thomas Bogs,
  • Nadia Saleh,
  • Suleyman Tolga Yavuz,
  • Walid Fazeli,
  • Rainer Ganschow and
  • Felix Schreiner

18 February 2022

We report a 15-year-old boy who developed aseptic meningitis 10 days after administration of the second dose of the COVID-19 vaccine BNT162b2. Although accompanying aphthous mouth ulcers resembling herpetic stomatitis initially led us to suspect an u...

  • Article
  • Open Access
12 Citations
3,748 Views
13 Pages

Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants

  • David Peterhoff,
  • Sebastian Einhauser,
  • Stephanie Beileke,
  • Hans-Helmut Niller,
  • Felix Günther,
  • Michael Schachtner,
  • Benedikt Asbach,
  • Philipp Steininger,
  • Matthias Tenbusch and
  • Klaus Überla
  • + 5 authors

18 February 2022

To assess vaccine immunogenicity in non-infected and previously infected individuals in a real-world scenario, SARS-CoV-2 antibody responses were determined during follow-up 2 (April 2021) of the population-based Tirschenreuth COVID-19 cohort study c...

  • Article
  • Open Access
2 Citations
4,063 Views
15 Pages

Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia

  • Yazed AlRuthia,
  • Haya F. Al-Salloum,
  • Omar A. Almohammed,
  • Amani S. Alqahtani,
  • Hana A. Al-Abdulkarim,
  • Yousef M. Alsofayan,
  • Sami S. Almudarra,
  • Sara H. AlQahtani,
  • Abdullah Almutlaq and
  • Yousif A. Asiri
  • + 4 authors

18 February 2022

Background: Saudi Arabia expedited the approval of some COVID-19 vaccines and launched mass vaccination campaigns. The aim of this study was to describe the demographics of vaccinated COVID-19 cases and compare the mortality rates of COVID-19 cases w...

  • Article
  • Open Access
12 Citations
5,766 Views
9 Pages

17 February 2022

Within a year after the emergence of SARS-CoV-2, several vaccines had been developed, clinically evaluated, proven to be efficacious in preventing symptomatic disease, and licensed for global use. The remaining questions about the vaccines concern th...

  • Article
  • Open Access
23 Citations
6,652 Views
14 Pages

The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data

  • Soonok Sa,
  • Chae Won Lee,
  • Sung Ryul Shim,
  • Hyounggyoon Yoo,
  • Jinwha Choi,
  • Ju Hee Kim,
  • Kiwon Lee,
  • Myunghee Hong and
  • Hyun Wook Han

17 February 2022

Two mRNA COVID-19 vaccines (mRNA-1273, Moderna; and BNT162b2, Pfizer-BioNTech) and one viral vector vaccine (JNJ-78436735, Janssen/Johnson and Johnson) are authorized in the US to hinder COVID-19 infections. We analyzed severe and common adverse even...

  • Article
  • Open Access
3 Citations
3,479 Views
13 Pages

Modulation of Inflammatory Signaling Molecules in Bordetella pertussis Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists

  • Md. Obayed Raihan,
  • Brenna M. Espelien,
  • Brett A. McGregor,
  • Courtney Hanson,
  • Afrina Brishti,
  • Nathan A. Velaris,
  • Travis D. Alvine,
  • David S. Bradley,
  • Matthew Nilles and
  • James E. Porter
  • + 2 authors

17 February 2022

BscF is a type III secretion system (T3SS) needle protein from Bordetella pertussis and has previously been shown to induce a sufficient Th1 and Th17 response in human monocytes and mice as a prerequisite for long-lasting protective immunity against...

  • Article
  • Open Access
7 Citations
3,378 Views
11 Pages

17 February 2022

Objectives: One dose of Sabin-strains inactivated polio vaccine (IPV) was introduced into the Chinese immunization program on 1 May 2016. This study aimed to evaluate the safety of Sabin-strains IPV and provide a comparison with conventional Salk-str...

  • Article
  • Open Access
12 Citations
3,826 Views
11 Pages

17 February 2022

Vaccination against brucellosis using live attenuated strains is the primary approach in protecting livestock against the disease through a strong cellular immune response. Attenuated vaccine strains also induce serum anti-Brucella antibodies, mostly...

  • Review
  • Open Access
29 Citations
11,678 Views
21 Pages

Clostridial Diseases of Horses: A Review

  • Francisco A. Uzal,
  • Mauricio A. Navarro,
  • Javier Asin and
  • Eileen E. Henderson

17 February 2022

The clostridial diseases of horses can be divided into three major groups: enteric/enterotoxic, histotoxic, and neurotoxic. The main enteric/enterotoxic diseases include those produced by Clostridium perfringens type C and Clostridioides difficile, b...

  • Article
  • Open Access
13 Citations
3,345 Views
15 Pages

Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies

  • Matthaios Speletas,
  • Ioanna Voulgaridi,
  • Styliani Sarrou,
  • Aikaterini Dadouli,
  • Varvara A. Mouchtouri,
  • Dimitrios J. Nikoulis,
  • Maria Tsakona,
  • Maria A. Kyritsi,
  • Athanasia-Marina Peristeri and
  • Christos Hadjichristodoulou
  • + 11 authors

17 February 2022

The aim of our study was to investigate the immunogenicity of the BNT162b2 vaccination according to the age and medical status of vaccinated individuals. A total of 511 individuals were enrolled (median age: 54.0 years, range: 19–105); 509 of t...

  • Article
  • Open Access
41 Citations
4,385 Views
15 Pages

17 February 2022

Tuberculosis vaccines (Bacillus Calmette-Guérin, BCG) were introduced 100 years ago and are still recommended by the World Health Organization to prevent the disease. Studies have shown that BCG vaccination can stimulate non-specific immune re...

  • Review
  • Open Access
9 Citations
5,750 Views
15 Pages

Adverse Events Reporting Quality of Randomized Controlled Trials of COVID-19 Vaccine Using the CONSORT Criteria for Reporting Harms: A Systematic Review

  • Cindra Tri Yuniar,
  • Bhekti Pratiwi,
  • Ardika Fajrul Ihsan,
  • Bambang Tri Laksono,
  • Iffa Risfayanti,
  • Annisa Fathadina,
  • Yeonseon Jeong and
  • Eunyoung Kim

17 February 2022

Background: Assessing the quality of evidence from vaccine clinical trials is essential to ensure the safety and efficacy of the vaccine and further enhance public acceptance. This study aims to summarize and critically evaluate the quality of harm r...

  • Review
  • Open Access
28 Citations
6,154 Views
17 Pages

Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005–2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine

  • Reyad Almoheer,
  • Mohd Effendy Abd Wahid,
  • Hidayatul Aini Zakaria,
  • Mohd Anuar Bin Jonet,
  • Muhanna Mohammed Al-shaibani,
  • Adel Al-Gheethi and
  • Siti Nor Khadijah Addis

17 February 2022

Hemorrhagic septicemia (HS) caused by Pasteurella multocida B:2 and E:2 is among the fatal bacterial diseases in cattle and buffaloes that are economically valuable in Asian and African countries. The current work aims to study the prevalence of HS a...

  • Article
  • Open Access
6 Citations
3,775 Views
14 Pages

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan

  • Jer-Hwa Chang,
  • Jeng-Fong Chiou,
  • Ching-Sheng Hung,
  • Ming-Che Liu,
  • Hui-Wen Chang,
  • Shiao-Ya Hong,
  • Cheng-Yi Wang,
  • Yi-Ling Lin,
  • Yi-Chen Hsieh and
  • Shih-Hsin Hsiao
  • + 16 authors

17 February 2022

Background: The ChAdOx1 nCoV-19 vaccine has been widely administered against SARS-CoV-2 infection; however, data regarding its immunogenicity, reactogenicity, and potential differences in responses among Asian populations remain scarce. Methods: 270...

  • Article
  • Open Access
14 Citations
4,795 Views
15 Pages

Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry

  • Ayla M. Tourkmani,
  • Abdulaziz Mansour Bin Rsheed,
  • Mohammad Saad AlEissa,
  • Sulaiman Mohammed Alqahtani,
  • Azzam Fahad AlOtaibi,
  • Mohammed S. Almujil,
  • Ibraheem H. AlKhshan,
  • Turki N. ALNassar,
  • Mansour N. ALOtaibi and
  • Alian A. Alrasheedy

16 February 2022

Patients with diabetes have a higher risk of severe infection and mortality due to COVID-19. Considering the current limited effective pharmacological treatments, vaccination remains one of the most effective means to control the pandemic. The curren...

  • Brief Report
  • Open Access
12 Citations
2,951 Views
7 Pages

Low Adherence to Pneumococcal Vaccination in Lung Cancer Patients in a Tertiary Care University Hospital in Southern Germany

  • Arno Mohr,
  • Mia Kloos,
  • Christian Schulz,
  • Michael Pfeifer,
  • Bernd Salzberger,
  • Stilla Bauernfeind,
  • Florian Hitzenbichler,
  • Annelie Plentz,
  • Thomas Loew and
  • Myriam Koch

16 February 2022

Introduction: The aim of this study was to investigate the adherence to vaccinations, especially pneumococcal vaccinations, in lung cancer patients. Methods: the study was performed at the University Hospital Regensburg, Germany. All patients with a...

  • Protocol
  • Open Access
13 Citations
5,003 Views
13 Pages

An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

  • Helen S. Marshall,
  • Prabha H. Andraweera,
  • James Ward,
  • John Kaldor,
  • Ross Andrews,
  • Kristine Macartney,
  • Peter Richmond,
  • Vicki Krause,
  • Ann Koehler and
  • Lisa Whop
  • + 11 authors

16 February 2022

Invasive meningococcal disease (IMD) causes significant morbidity and mortality worldwide with serogroup B being the predominant serogroup in Australia and other countries for the past few decades. The licensed 4CMenB vaccine is effective in preventi...

  • Article
  • Open Access
3 Citations
4,162 Views
15 Pages

Protease-Based Subunit Vaccine in Mice Boosts BCG Protection against Mycobacterium tuberculosis

  • Ana Paula Junqueira-Kipnis,
  • Carine de Castro Souza,
  • Ana Carolina de Oliveira Carvalho,
  • Fabio Muniz de Oliveira,
  • Vinnycius Pereira Almeida,
  • Alisson Rodrigues de Paula,
  • Mara Rubia Celes and
  • André Kipnis

16 February 2022

The significant number of people with latent and active tuberculosis infection requires further efforts to develop new vaccines or improve the Bacillus Calmette-Guérin (BCG), which is the only approved vaccine against this disease. In this stu...

  • Review
  • Open Access
27 Citations
14,878 Views
23 Pages

Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated?

  • Aniello Maiese,
  • Arianna Baronti,
  • Alice Chiara Manetti,
  • Marco Di Paolo,
  • Emanuela Turillazzi,
  • Paola Frati and
  • Vittorio Fineschi

16 February 2022

More than eight billion doses of COVID-19 vaccines have been administered globally so far and 44.29% of people are fully vaccinated. Pre-authorization clinical trials were carried out and the safety of vaccines is still continuously monitored through...

  • Article
  • Open Access
9 Citations
3,436 Views
11 Pages

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles

  • Xinyue Chang,
  • Xuelan Liu,
  • Mona O. Mohsen,
  • Andris Zeltins,
  • Byron Martina,
  • Monique Vogel and
  • Martin F. Bachmann

16 February 2022

The impact of the COVID-19 pandemic has been reduced since the application of vaccination programs, mostly shown in the reduction of hospitalized patients. However, the emerging variants, in particular Omicron, have caused a steep increase in the num...

  • Article
  • Open Access
13 Citations
5,715 Views
36 Pages

A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protects Pigs against PCV2b Challenge and Induces Serum Neutralizing Antibody Response against CSFV

  • Selvaraj Pavulraj,
  • Katrin Pannhorst,
  • Rhett W. Stout,
  • Daniel B. Paulsen,
  • Mariano Carossino,
  • Denise Meyer,
  • Paul Becher and
  • Shafiqul I. Chowdhury

16 February 2022

Porcine circovirus type 2 (PCV2) is endemic worldwide. PCV2 causes immunosuppressive infection. Co-infection of pigs with other swine viruses, such as pseudorabies virus (PRV) and classical swine fever virus (CSFV), have fatal outcomes, causing the s...

  • Review
  • Open Access
10 Citations
3,536 Views
14 Pages

16 February 2022

Recent years have brought major advancements in the use of immune therapy and specifically immune checkpoint inhibitors (ICIs) in cancer patients, with expanding indications for various malignancies resulting in the treatment of a large and increasin...

  • Review
  • Open Access
69 Citations
10,843 Views
16 Pages

16 February 2022

While the role of active smoking on response to vaccines is yet to be fully understood, some real-world studies have outlined a possible link between smoking and humoral response to COVID-19 vaccines. Thus, the present rapid systematic review aimed a...

  • Case Report
  • Open Access
30 Citations
10,981 Views
13 Pages

New-Onset Kidney Diseases after COVID-19 Vaccination: A Case Series

  • Jeong-Hoon Lim,
  • Mee-Seon Kim,
  • Yong-Jin Kim,
  • Man-Hoon Han,
  • Hee-Yeon Jung,
  • Ji-Young Choi,
  • Jang-Hee Cho,
  • Chan-Duck Kim,
  • Yong-Lim Kim and
  • Sun-Hee Park

16 February 2022

Various vaccines against COVID-19 have been developed and proven to be effective, but their side effects, especially on kidney function, are not yet known in detail. In this study, we report the clinical courses and histopathologic findings of new-on...

  • Article
  • Open Access
9 Citations
4,874 Views
37 Pages

16 February 2022

The COVID-19 origin debate has greatly been influenced by genome comparison studies of late, revealing the emergence of the Furin-like cleavage site at the S1/S2 junction of the SARS-CoV-2 Spike (FLCSSpike) containing its 681PRRAR685 motif, absent in...

  • Brief Report
  • Open Access
4 Citations
3,887 Views
7 Pages

An Attenuated HSV-1-Derived Malaria Vaccine Expressing Liver-Stage Exported Proteins Induces Sterilizing Protection against Infectious Sporozoite Challenge

  • Paul J. F. Rider,
  • Mohd Kamil,
  • Ilknur Yilmaz,
  • Habibe N. Atmaca,
  • Merve Kalkan-Yazici,
  • Mehmet Ziya Doymaz,
  • Konstantin G. Kousoulas and
  • Ahmed S. I. Aly

16 February 2022

Here, we present the construction of an attenuated herpes simplex virus type-1 (HSV-1)-vectored vaccine, expressing three liver-stage (LS) malaria parasite exported proteins (EXP1, UIS3 and TMP21) as fusion proteins with the VP26 viral capsid protein...

  • Article
  • Open Access
10 Citations
4,499 Views
10 Pages

COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study

  • Helena Garcia-Llana,
  • Nayara Panizo,
  • Lorena Gandía,
  • Marisa Orti,
  • Elena Giménez-Civera,
  • Claudia Forquet,
  • Luis D’Marco,
  • Maria Jesús Puchades,
  • Mari Sargsyan and
  • Jose Luis Górriz
  • + 9 authors

16 February 2022

The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients,...

  • Case Report
  • Open Access
1 Citations
2,536 Views
6 Pages

15 February 2022

Safe and effective vaccines are available to face the global threat of the COVID-19 pandemic. In this article, we report on the clinical cases of two healthcare workers vaccinated with two doses of BNT162b2 vaccine who were infected by the same viral...

  • Review
  • Open Access
24 Citations
7,229 Views
24 Pages

Progress towards the Elusive Mastitis Vaccines

  • Pascal Rainard,
  • Florence B. Gilbert,
  • Rodrigo P. Martins,
  • Pierre Germon and
  • Gilles Foucras

15 February 2022

Mastitis is a major problem in dairy farming. Vaccine prevention of mammary bacterial infections is of particular interest in helping to deal with this issue, all the more so as antibacterial drug inputs in dairy farms must be reduced. Unfortunately,...

  • Review
  • Open Access
22 Citations
7,129 Views
28 Pages

Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review

  • Beatriz Garcillán,
  • Miguel Salavert,
  • José R. Regueiro and
  • Sabela Díaz-Castroverde

15 February 2022

Patients with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis and inflammatory bowel disease, are at increased risk of infection. International guidelines recommend vaccination to limit this risk of infection, although liv...

  • Article
  • Open Access
4 Citations
3,809 Views
23 Pages

E4orf1 Suppresses E1B-Deleted Adenovirus Vaccine-Induced Immune Responses

  • Kotou Sangare,
  • Sabrina Helmold Hait,
  • Madison Moore,
  • Christopher Hogge,
  • Tanya Hoang,
  • Mohammad Arif Rahman,
  • David J. Venzon,
  • Celia LaBranche,
  • David Montefiori and
  • Michael A. Thomas
  • + 1 author

15 February 2022

As demonstrated by the recent COVID pandemic, vaccines can reduce the burden arising from infectious agents. Adenoviruses (Ads) with deletion of the early region 1B55K (ΔE1B Ad) are currently being explored for use in vaccine delivery. ΔE...

  • Review
  • Open Access
14 Citations
6,319 Views
21 Pages

Vaccines, Microbiota and Immunonutrition: Food for Thought

  • Laura Di Renzo,
  • Laura Franza,
  • Diego Monsignore,
  • Ernesto Esposito,
  • Pierluigi Rio,
  • Antonio Gasbarrini,
  • Giovanni Gambassi,
  • Rossella Cianci and
  • Antonino De Lorenzo

15 February 2022

Vaccines are among the most effective health measures and have contributed to eradicating some diseases. Despite being very effective, response rates are low in some individuals. Different factors have been proposed to explain why some people are not...

  • Article
  • Open Access
18 Citations
3,523 Views
14 Pages

Influenza Vaccination Uptake in the General Italian Population during the 2020–2021 Flu Season: Data from the EPICOVID-19 Online Web-Based Survey

  • Andrea Giacomelli,
  • Massimo Galli,
  • Stefania Maggi,
  • Marianna Noale,
  • Caterina Trevisan,
  • Gabriele Pagani,
  • Raffaele Antonelli-Incalzi,
  • Sabrina Molinaro,
  • Luca Bastiani and
  • Fulvio Adorni
  • + 4 authors

15 February 2022

To assess influenza vaccine uptake during the 2020/2021 flu season and compare it with that of the 2019/2020 flu season among respondents to the second phase of the web-based EPICOVID-19 survey, we performed an observational web-based nationwide onli...

of 5

XFacebookLinkedIn
Vaccines - ISSN 2076-393X